6O47
human cGAS core domain (K427E/K428E) bound with RU-521
6O47 の概要
| エントリーDOI | 10.2210/pdb6o47/pdb |
| 分子名称 | Cyclic GMP-AMP synthase, CITRIC ACID, ZINC ION, ... (6 entities in total) |
| 機能のキーワード | human, cgas, core domain, compound, ru-521, dna binding protein, transferase |
| 由来する生物種 | Homo sapiens (Human) |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 44766.16 |
| 構造登録者 | Xie, W.,Lama, L.,Adura, C.,Glickman, J.F.,Tuschl, T.,Patel, D.J. (登録日: 2019-02-28, 公開日: 2019-05-29, 最終更新日: 2023-10-11) |
| 主引用文献 | Xie, W.,Lama, L.,Adura, C.,Tomita, D.,Glickman, J.F.,Tuschl, T.,Patel, D.J. Human cGAS catalytic domain has an additional DNA-binding interface that enhances enzymatic activity and liquid-phase condensation. Proc.Natl.Acad.Sci.USA, 116:11946-11955, 2019 Cited by PubMed Abstract: The cyclic GMP-AMP synthase (cGAS)-cGAMP-STING pathway plays a key role in innate immunity, with cGAS sensing both pathogenic and mislocalized DNA in the cytoplasm. Human cGAS (h-cGAS) constitutes an important drug target for control of antiinflammatory responses that can contribute to the onset of autoimmune diseases. Recent studies have established that the positively charged N-terminal segment of cGAS contributes to enhancement of cGAS enzymatic activity as a result of DNA-induced liquid-phase condensation. We have identified an additional cGAS-DNA interface (labeled site-C; CD, catalytic domain) in the crystal structure of a human SRY.cGAS-DNA complex, with mutations along this basic site-C cGAS interface disrupting liquid-phase condensation, as monitored by cGAMP formation, gel shift, spin-down, and turbidity assays, as well as time-lapse imaging of liquid droplet formation. We expand on an earlier ladder model of cGAS dimers bound to a pair of parallel-aligned DNAs to propose a multivalent interaction-mediated cluster model to account for DNA-mediated condensation involving both the N-terminal domain of cGAS and the site-C cGAS-DNA interface. We also report the crystal structure of the h-cGAS-DNA complex containing a triple mutant that disrupts the site-C interface, with this complex serving as a future platform for guiding cGAS inhibitor development at the DNA-bound h-cGAS level. Finally, we solved the structure of RU.521 bound in two alternate alignments to apo h-cGAS, thereby occupying more of the catalytic pocket and providing insights into further optimization of active-site-binding inhibitors. PubMed: 31142647DOI: 10.1073/pnas.1905013116 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.196 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






